ROST
61
5
DUK
60
5
ITW
33
2
ABBV
51
-4
BWA
38
-6
PCG
58
-8
SYF
71
-3
NDAQ
50
4
RIG
41
-6
DIS
73
-2
VIX
55
-5
TGNA
48
-2
EXC
67
6
NRG
35
3
WYNN
28
-2
FLR
48
-4
DFS
68
-2
MA
46
2
GT
41
-2
EQT
56
2
ROST
61
5
DUK
60
5
ITW
33
2
ABBV
51
-4
BWA
38
-6
PCG
58
-8
SYF
71
-3
NDAQ
50
4
RIG
41
-6
DIS
73
-2
VIX
55
-5
TGNA
48
-2
EXC
67
6
NRG
35
3
WYNN
28
-2
FLR
48
-4
DFS
68
-2
MA
46
2
GT
41
-2
EQT
56
2
Financhill
Back

First Capital REIT Vs. Janux Therapeutics Industry Stock Comparison

Sell
22

FCXXF
First Capital REIT

Last Price:
$11.88
Seasonality Move:
0.87%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
22
First Capital REIT (FCXXF) is a Sell

Is First Capital REIT a Buy, Sell or Hold?

  • The current First Capital REIT [FCXXF] share price is $11.88. The Score for FCXXF is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • FCXXF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCXXF Stock Price Chart

What is First Capital REIT's stock price today?

  • The First Capital REIT share price today is $11.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCXXF is experiencing slight buying pressure.

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

FCXXF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.19 Sell
Relative Strength Index (14 RSI): 37.57 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.93 - 12.87) Sell
Bollinger Bands (100): (12.33 - 13.45) Sell

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

FCXXF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.28 Sell
20-day SMA: 12.36 Sell
50-day SMA: 12.62 Sell
200-day SMA: 12.04 Sell
8-day EMA: 12.11 Sell
20-day EMA: 12.34 Sell
50-day EMA: 12.56 Sell
200-day EMA: 12.25 Sell

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

First Capital REIT Earnings Growth & FCXXF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

First Capital REIT Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):